IPO Partners With Ateb
Ateb and Improved Patient Outcomes (IPO) Announce A Partnership To Deliver Pharmacy-Enabled Population Health Management Solutions
(November 21st, 2016) Raleigh, N.C., – Ateb®, Inc., the industry’s leading provider of Pharmacy-Based Patient Care Solutions, with over one million patients enrolled in its Time My Meds®, medication synchronization solution and Improved Patient Outcomes®, Inc. (IPO), the market leader providing behavioral based patient engagement and medication adherence solutions, announced today a partnership to offer population health management solutions to improve medication adherence through changes in patient behaviors.
The combination of IPO’s outcomes based technology with Duke University’s evidence-based behavioral content complements Ateb’s Appointment-Based Model (ABM) which allows pharmacies to actively engage patients to help them better manage their medications appropriately to improve their health outcomes. This collaboration leverages Ateb’s pharmacy network and data integration technology with IPO’s behavioral solution across 90 disease states.
By integrating IPO’s proven behavioral content into Ateb’s online Patient Management Access Portal (PMAP), Ateb’s pharmacy partners can identify high risk patients and use predictive indicators to take the appropriate steps to help them understand their chronic disease states and lower their risk factors.
“By augmenting our technology with evidenced-based behavioral content, our valued pharmacy partners can make a substantial difference in their patients’ medication adherence, leading to healthier outcomes for the patients and also demonstrates the ability for pharmacy to deliver more accessible and affordable healthcare,” stated Frank Sheppard, President and CEO of Ateb.
Utilizing Ateb’s existing patient communication solution, including outbound calls, texts and push notifications, pharmacies can develop simple, effective communication protocols to drive proactive behavioral interventions that establish lasting behavioral changes in patients.
“Our proven behavioral solution empowers pharmacists to engage patients in a more sustainable and meaningful way; leveraging technology to increase scale and efficiency while deploying proven behavioral change interventions via digital channels,” stated Greg Muffler, CEO of Improved Patient Outcomes.
About Ateb, Inc. Ateb is the trusted source for independent and chain pharmacies seeking measurable pharmacy-based patient care solutions that improve pharmacy performance and patient outcomes. Ateb’s patented technologies and robust analytics provide pharmacies with real proof of performance regarding patient care outcomes that generate new revenue streams.
Ateb’s Patient Management Access Portal is the nexus of Ateb’s entire portfolio of patient care solutions and the leading driver of pharmacy’s appointment-based model in the market today. By combining Ateb's proprietary blend of pharmacy operational expertise, technology, analytics, and data integration, Ateb is driving healthy outcomes for patients, pharmacies, and payers. To learn more, please visit; http://www.ateb.com
Time My Meds® is a registered trademark of Ateb, Inc.
About Improved Patient Outcomes, Inc., (IPO)
IPO is a market leader in multi-channel behavior change content. The foundation of IPO, a joint venture between Duke University Department of Medicine and the private sector, is a rich library of dynamic, evidence-based behavioral intervention content for more than 90 disease states. The $80 million body of research has been compiled at Duke University over the past 198 years under the leadership of Dr. Hayden Bosworth of Duke University and commercialized exclusively by IPO. IPO works with pharmaceutical manufacturers, payers and providers to improve patient adherence, engagement and outcomes. IPO was recently recognized as one of the most innovative companies in the pharmaceutical industry by editors of PM360. To learn more, please visit; http://www.ipohealthmatters.com